A growing mass of evidence highlighted that BAG3 plays a role in the development, prognosis, and resistance to treatment of over 10 different types of cancer, including the aggressive pancreatic ductal adenocarcinomas, and the high expression of the protein in these cancer cells correlates with increased resistance to chemotherapeutics [11,12]. Here, BAG3 is linked to cancer.